For many years cardiovascular disease has been the number one cause of death among diabetes patients. So getting a CV benefit from diabetes drugs is a definite plus. Over the past few weeks Dr. Aaron Vinik has been sharing his views on the values of Cycloset for both diabetes and …

Patients with type 2 diabetes usually do not die from diabetes, but from cardiovascular disease and strokes.

Benefits of exercise shown to depend on duration, not exercise type

Study finds linoleic acid has long-term benefits in diabetes prevention, arachidonic acid not harmful.

Statin therapy may be elevating risk of type 2 diabetes in high-risk adults.

SEARCH For Diabetes In Youth Study finds more at risk of developing diabetic peripheral neuropathy than previously thought.

By Guest Writer David Kliff, Publisher, Diabetic Investor: Although it has taken much longer than I anticipated, market dynamics are forcing companies to think differently and we are now on the verge of patients being prescribed diabetes management systems rather than individual pieces of the system.

You have decided that one of your patients, a 72-year-old, should add a basal insulin dose to her antihyperglycemic regimen. During your discussion with her, she voices concern that between her “arthritic hands and poor vision” she won’t be able to accomplish this. You make the recommendation that using an insulin pen will make injection easier for her. Which of the following statements regarding insulin pens is true? A. They all require loading with an insulin cartridge. B. They have more accurate dosing than syringes. C. They can now dose insulin in .10 units increments. D. They are now available for all types of insulin. Follow the link for the answer.

Are all your patients who use insulin pens trained and know how to use a vial and syringe? Follow the link to see how you and your colleagues compare.

Dr. Carla Greenbaum is the Director of the Diabetes Research Program at Benaroya Research Institute at Virginia Mason in Seattle, WA.